The ACT-Accelerator and Multilateral Leaders Task Force Global COVID-19 Access Tracker (GCAT) is a dynamic tool to transparently track progress towards the global targets for access to COVID-19 vaccines, treatments, tests and PPE.
Vaccination
Today, vaccines are still the most effective tool to prevent severe disease and death, and lower transmission. The global vaccination target is to achieve 70% primary series coverage in all countries by mid-2022 – with, as utmost priority, vaccinating the most vulnerable populations such as healthcare workers, populations over the age of 60 and at-risk groups.
Testing
The diagnostics target is for all countries to achieve testing rates of 1 per 1,000 people per day in 2022. Testing is needed to identify disease hotspots and track the emergence of new, dangerous variants.
Therapeutics
The therapeutics target is to treat all severe cases of COVID-19. Treatments, including medical oxygen, are needed for those severely affected by COVID-19 or to prevent those in at-risk groups from progressing to severe disease.
Protection of Health Workers
The target is to ensure that health and community care workers have the necessary personal protective equipment and training to apply appropriate infection prevention and control practices.
Collaboration and Partners
The Access to COVID-19 Tools (ACT) Accelerator and the Multilateral Leaders Task Force on Scaling COVID-19 Tools are groundbreaking global collaborations to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Launched at the beginning of the pandemic, these partnerships bring together governments, scientists, businesses, civil society, philanthropists, global health and finance organizations. The ACT-Accelerator agencies are the Bill & Melinda Gates Foundation, CEPI, FIND Test Tracker, Gavi, The Global Fund, UNICEF, Unitaid, Wellcome, WHO, and the World Bank. The Multilateral Leaders Task Force comprises WHO, the WTO, the World Bank and the IMF.
These organizations have joined forces to speed up an end to the pandemic by supporting the development and equitable distribution of the tests, treatments and vaccines the world needs to reduce mortality and severe disease, restoring full societal and economic activity globally in the near term, and facilitating high-level control of COVID-19 disease in the medium term.
Partner's tools include IMF-WHO COVID-19 Vaccine Tracker.
There is no time to waste in the fight against COVID-19. No one is safe until everyone is safe.
Disclaimer: The ACT-A and MLT accept no responsibility whatsoever for any inaccurate or incomplete information or data that may be included in this database, and expressly disclaims any liability for damages as a result of its use. The responsibility for the interpretation and use of the content lies with the user. The ACT-A and MLT assume no responsibility or liability for any consequence resulting directly or indirectly from any action or inaction users take based on or made in reliance on the information and data available in this database.
The designations employed and the presentation of the material do not imply the expression of any opinion whatsoever on the part of the institutions concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
Any mention of countries refers to countries, territories, and areas. A total of 234 countries, territories, and areas are included in the Global COVID-19 Access Tracker.